Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Chromosome 11 putative open reading frame 40 (C11orf40)** is classified as a long non-coding RNA (lncRNA) gene rather than a protein-coding gene and is primarily identified through genomic studies with little experimental characterization regarding its biological functions or disease associations. It is not considered a therapeutic target, enzyme, receptor, transporter, or member of a known functional protein family. Aliases include NOV1 and Ro/SSA1-related protein, but these do not reflect known, verified protein or receptor activity. There is no evidence for interaction with drugs, known mechanisms of action, biomarker usage, or safety concerns in the therapeutic context. Its function and clinical significance remain largely unknown[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 11 putative open reading frame 40 (C11orf40).